Scope of the Report:
The worldwide market for Radiopharmaceuticals in Nuclear Medicine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Radiopharmaceuticals in Nuclear Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market Segment by Applications, can be divided into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales, revenue and global market share of Radiopharmaceuticals in Nuclear Medicine in 2017 and 2018.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Radiopharmaceuticals in Nuclear Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic Radiopharmaceuticals
1.2.2 Therapy Radiopharmaceuticals
1.2.3 Enriched Stable Isotopes
1.3 Market Analysis by Applications
1.3.1 Diagnostic Application
1.3.2 Therapeutic Application
1.3.3 Research
1.3.4 Pharmaceutical
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bracco Imaging S.P.A.
2.1.1 Business Overview
2.1.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cambridge Isotope Laboratories, Inc.
2.2.1 Business Overview
2.2.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cardinal Health, Inc.
2.3.1 Business Overview
2.3.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Covidien, Plc
2.4.1 Business Overview
2.4.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Eczacibasi-Monrol
2.5.1 Business Overview
2.5.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Fujifilm Holdings Corporation
2.6.1 Business Overview
2.6.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 GE Healthcare (Subsidiary Of General Electric Company)
2.7.1 Business Overview
2.7.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 IBA Group
2.8.1 Business Overview
2.8.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Isotec, Inc. (Sigma-Aldrich)
2.9.1 Business Overview
2.9.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lantheus Medical Imaging, Inc.
2.10.1 Business Overview
2.10.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Nordion, Inc.
2.11.1 Business Overview
2.11.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Ntp Radioisotopes (Pty), Ltd.
2.12.1 Business Overview
2.12.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
2.13.1 Business Overview
2.13.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Taiyo Nippon Sanso Corporation
2.14.1 Business Overview
2.14.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Urenco Limited
2.15.1 Business Overview
2.15.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Rotem Industries, Ltd., Inc.
2.16.1 Business Overview
2.16.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Australian Nuclear Association And Technology Organization (ANSTO)
2.17.1 Business Overview
2.17.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Board of Radiation And Isotope Technology (BRIT)
2.18.1 Business Overview
2.18.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Institute of Atomic Energy Polatom Radioisotope Centre
2.19.1 Business Overview
2.19.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Institute of Isotopes Co., Ltd.
2.20.1 Business Overview
2.20.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Institute Of Radioelement (IRE)
2.21.1 Business Overview
2.2.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2018
3.3.2 Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Radiopharmaceuticals in Nuclear Medicine Market Analysis by Regions
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Regions (2014-2019)
4.2 North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
4.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
4.5 South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
5 North America Radiopharmaceuticals in Nuclear Medicine by Country
5.1 North America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
5.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
5.2 United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
5.3 Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
5.4 Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
6 Europe Radiopharmaceuticals in Nuclear Medicine by Country
6.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
6.2 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
6.3 UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
6.4 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
6.5 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
6.6 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine by Country
7.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
7.2 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
7.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
7.4 Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
7.5 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
8 South America Radiopharmaceuticals in Nuclear Medicine by Country
8.1 South America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
8.1.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
8.3 Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
8.4 Colombia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Countries
9.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
9.3 Turkey Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
9.4 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
9.5 Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
9.6 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
10 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Type
10.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2014-2019)
10.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2014-2019)
10.2 Diagnostic Radiopharmaceuticals Sales Growth and Price
10.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth (2014-2019)
10.2.2 Global Diagnostic Radiopharmaceuticals Price (2014-2019)
10.3 Therapy Radiopharmaceuticals Sales Growth and Price
10.3.1 Global Therapy Radiopharmaceuticals Sales Growth (2014-2019)
10.3.2 Global Therapy Radiopharmaceuticals Price (2014-2019)
10.4 Enriched Stable Isotopes Sales Growth and Price
10.4.1 Global Enriched Stable Isotopes Sales Growth (2014-2019)
10.4.2 Global Enriched Stable Isotopes Price (2014-2019)
11 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Application
11.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2014-2019)
11.2 Diagnostic Application Sales Growth (2014-2019)
11.3 Therapeutic Application Sales Growth (2014-2019)
11.4 Research Sales Growth (2014-2019)
11.5 Pharmaceutical Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate (2019-2024)
12.2 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions (2019-2024)
12.2.1 North America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.2.4 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
12.3 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Type (2019-2024)
12.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2019-2024)
12.3.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Type (2019-2024)
12.4 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Application (2019-2024)
12.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2019-2024)
12.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Radiopharmaceuticals in Nuclear Medicine Picture
Table Product Specifications of Radiopharmaceuticals in Nuclear Medicine
Figure Global Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Types in 2018
Table Radiopharmaceuticals in Nuclear Medicine Types for Major Manufacturers
Figure Diagnostic Radiopharmaceuticals Picture
Figure Therapy Radiopharmaceuticals Picture
Figure Enriched Stable Isotopes Picture
Figure Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Applications in 2018
Figure Diagnostic Application Picture
Figure Therapeutic Application Picture
Figure Research Picture
Figure Pharmaceutical Picture
Figure Other Picture
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure France Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2014-2024)
Table Bracco Imaging S.P.A. Basic Information, Manufacturing Base and Competitors
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cardinal Health, Inc. Basic Information, Manufacturing Base and Competitors
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Covidien, Plc Basic Information, Manufacturing Base and Competitors
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eczacibasi-Monrol Basic Information, Manufacturing Base and Competitors
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base and Competitors
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table IBA Group Basic Information, Manufacturing Base and Competitors
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base and Competitors
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base and Competitors
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nordion, Inc. Basic Information, Manufacturing Base and Competitors
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ntp Radioisotopes (Pty), Ltd. Basic Information, Manufacturing Base and Competitors
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base and Competitors
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Urenco Limited Basic Information, Manufacturing Base and Competitors
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Rotem Industries, Ltd., Inc. Basic Information, Manufacturing Base and Competitors
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Manufacturing Base and Competitors
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Board of Radiation And Isotope Technology (BRIT) Basic Information, Manufacturing Base and Competitors
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Manufacturing Base and Competitors
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Institute of Isotopes Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Institute Of Radioelement (IRE) Basic Information, Manufacturing Base and Competitors
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Type and Applications
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturer (2017-2018)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturer in 2017
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturer in 2018
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2017-2018)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturer in 2017
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2018
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2018
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2014
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2018
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2014
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2018
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2017
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2018
Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries 2018
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries 2018
Figure China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2018
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2018
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Colombia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2018
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2014-2019)
Figure Global Diagnostic Radiopharmaceuticals Sales Growth (2014-2019)
Figure Global Diagnostic Radiopharmaceuticals Price (2014-2019)
Figure Global Therapy Radiopharmaceuticals Sales Growth (2014-2019)
Figure Global Therapy Radiopharmaceuticals Price (2014-2019)
Figure Global Enriched Stable Isotopes Sales Growth (2014-2019)
Figure Global Enriched Stable Isotopes Price (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2014-2019)
Figure Global Therapeutic Application Sales Growth (2014-2019)
Figure Global Research Sales Growth (2014-2019)
Figure Global Pharmaceutical Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
Figure Europe Sales Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
Figure South America Sales Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Type (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2019-2024)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
